Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Microorganisms in Vertebrate Digestive Systems

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1579149

SADI-S and SG surgeries induce distinct bile acid profiles linked to improved glucose metabolism via microbiota interactions

Provisionally accepted
Subo  MaSubo Ma1Zhang  ZhengZhang Zheng1Zhiqiang  WeiZhiqiang Wei1Lifu  HuLifu Hu1Lun  WangLun Wang2Zhubin  ShenZhubin Shen1Chaonv  FangChaonv Fang3Tao  JiangTao Jiang1*
  • 1Jilin University, Changchun, China
  • 2Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou Province, China
  • 3First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China

The final, formatted version of the article will be published soon.

Introduction: Although bariatric surgery profoundly ameliorates type 2 diabetes (T2D), the mechanisms whereby specific procedures confer metabolic benefits through bile acid (BA) remodeling remain incompletely defined. This study compared the effects of single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) and sleeve gastrectomy (SG) on BA profiles and their association with metabolic outcomes in a rodent model of T2D. Methods: Male Wistar rats with T2D underwent SADI-S, SG, or sham operation. Metabolic parameters, including fasting blood glucose, HbA1c, glucagon-like peptide-1 levels, triglycerides, gut microbiota composition, and comprehensive serum/faecal BA profiles, were assessed five weeks post-surgery. Statistical analyses included t-tests and Pearson correlations, with false discovery rate correction applied. Results: Both SADI-S and SG significantly ameliorated hyperglycemia, dyslipidemia, and β-cell integrity compared to sham operation, with SADI-S demonstrating superior efficacy. SADI-S induced a more pronounced elevation of portal serum BAs (34 vs. 25 species in SG), including key regulators such as chenodeoxycholic acid and lithocholic acid. Critically, multiple elevated serum BAs (e.g., chenodeoxycholic acid, lithocholic acid, glycoursodeoxycholic acid) exhibited strong negative correlations with fasting blood glucose, HbA1c, and triglycerides, while positively correlating with glucagon-like peptide-1 levels. Shifts in gut microbiota correlated with specific BA changes, supporting a 'microbiota-BA-metabolism' axis. Conclusions: SADI-S and SG induce distinct, surgery-specific BA remodeling that is significantly associated with metabolic improvements in T2D. The robust correlations between specific BA species and metabolic parameters underscore their potential as mediators and therapeutic targets. SADI-S promotes a more extensive and beneficial BA profile, aligning with its superior metabolic efficacy.

Keywords: Single-anastomosis duodenal-ileal bypass with sleeve gastrectomy, sleeve gastrectomy, Bile acid, Gut Microbiota, T2D

Received: 19 Feb 2025; Accepted: 08 Sep 2025.

Copyright: © 2025 Ma, Zheng, Wei, Hu, Wang, Shen, Fang and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Tao Jiang, Jilin University, Changchun, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.